Evaluating the efficacy of homoeopthic medicine Terebinthinae Oleum 30CH in treating urinary tract infection among teens and early adults: randomized control trial

Phase 4

• Conditions: Health Condition 1: N390- Urinary tract infection, site notspecified

• Registration Number: CTRI/2023/09/058041
• Lead Sponsor: Sibin R A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Clinical signs with one or more symptoms of a UTI.

Onset of symptoms < 24 hours prior to study entry

Exclusion Criteria

Three or more episodes of acute UTI in the past 12 months;

Known structural Genito-urinary abnormality patients

Patients with evidence of factors like calculi, stricture, primary renal disease (e.g.,

polycystic renal disease), or neurogenic bladder;

Patients with significant impaired immunity secondary to chemotherapy, oral

corticosteroids.

Patients with onset of symptoms > 24 hours prior to entry.

Patients with temperature = 103°F.

Patients who received treatment with other antimicrobials within 48 hours prior to

enrollment.

Any significant medical or psychiatric condition that would render examination

difficult or invalid or prevent the subject from active study participation.

Patients under other medications or concomitant therapies which interfere the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified